PIPages
Labs

Yuefeng Huang

Columbia University, NY·Microbiology & Immunology

Pneumonia is the only infectious disease among the top ten causes of death in the United States. Bacterial pneumonia, such as infection with Pseudomonas aeruginosa, causes heavy inflammation and damages the lung's blood vessels.

Fields

Microbiology & Immunology

Medicine & Clinical Research

Biology

Topics

immunology

innate immunity

innate lymphoid cells

Grants
1 known grant, through Apr 2029

What they work on

  1. Define the location and response dynamics of a newly identified group of innate lymphoid cells inside lung blood vessels (vILC3s) during infection, using mouse models, single-cell analysis and 3-D tissue imaging.
  2. Test whether vILC3s clear Pseudomonas aeruginosa from the lung by releasing the signal CCL4 to recruit bacteria-killing neutrophils, using ILC3-depletion mouse models and CCL4 neutralization.
  3. Test whether vILC3s promote regrowth of damaged lung blood vessels after infection by releasing CSF1 to expand macrophages, using mouse genetics and in vitro assays.

More about the research

The body therefore needs an immune response that both clears the bacteria and repairs the tissue. Group 3 innate lymphoid cells (ILC3s), immune cells that respond quickly to microbes in tissues, appear to play a part, but how they do so is poorly understood.

Why it matters

Bacterial pneumonia, including infection with Pseudomonas aeruginosa, is a leading cause of death and can leave lasting lung damage. Understanding how a newly identified group of immune cells inside lung blood vessels helps clear bacteria and rebuild vessels could provide a framework for new therapies. Such therapies could help patients fight lung infection and recover lung function afterward.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Lung vascular ILC3 subpopulation in anti-bacteria immunity and vasculature regeneration

NIH · Aug 2025 – Apr 2029

Closest labs

Samithamby Jeyaseelan

Louisiana State University, LA·Microbiology & Immunology

Determine how the antioxidant regulator Nrf2 affects survival, bacterial clearance and neutrophil accumulation and function during carbapenem-resistant Klebsiella pneumoniae (CRKP) pneumonia in mice.

Ari B Molofsky

University of California-San Francisco, CA·Microbiology & Immunology

Test how early injury-associated myofibroblasts, which depend on TGFβ signaling and macrophages, limit brain lesion size and loss of function in mouse models of brain injury.

Shelton Wright

University of Washington, WA·Microbiology & Immunology·Early-career

Determine the role of gamma-delta T cells, mucosa-enriched T cells that respond rapidly like innate immune cells, in driving lung inflammation during pulmonary melioidosis in vivo.

The school

Columbia University: 89 labs on PI Pages, $1.4B a year on research, 625 research doctorates a year.

More about Columbia University

Reach out

A start for your email. Fill in the brackets.